Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Methotrexate/oseltamivir

EBV reactivation and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lee B. IATROGENIC IMMUNODEFICIENCYASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN A PATIENT WITH RHEUMATOID ARTHRITIS. Journal of Hospital Medicine 18 (Suppl. 1): S627, Mar 2023. Available from: URL: http://doi.org/10.1002/jhm.13090 [abstract] Lee B. IATROGENIC IMMUNODEFICIENCYASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN A PATIENT WITH RHEUMATOID ARTHRITIS. Journal of Hospital Medicine 18 (Suppl. 1): S627, Mar 2023. Available from: URL: http://​doi.​org/​10.​1002/​jhm.​13090 [abstract]
Metadaten
Titel
Methotrexate/oseltamivir
EBV reactivation and lack of efficacy: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42386-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Phenazopyridine

Case report

Methotrexate

Case report

Rituximab

Case report

Denosumab